Table 3: Estimated risk of childhood prescription of medications for attention-deficit/hyperactivity disorder among children born to birth parents admitted for delivery between 31 + 0 and 33 + 6 weeks’ gestation versus those admitted between 34 + 0 and 36 + 6 weeks’ gestation in British Columbia, Canada, 2000–2013